HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Anastasios Georgoulis Selected Research
Anastasios Georgoulis Research Topics
Disease
1
Cardiotoxicity
03/2024
1
Ischemia
01/2021
1
Infarction (Infarctions)
01/2021
1
Reperfusion Injury
01/2021
1
Necrosis
04/2020
1
Genomic Instability
09/2017
1
Carcinogenesis
09/2017
1
Breast Neoplasms (Breast Cancer)
12/2012
1
Neoplasm Metastasis (Metastasis)
12/2012
1
Neoplasms (Cancer)
12/2012
1
Acquired Immunodeficiency Syndrome (AIDS)
06/2012
1
Osteoarthritis
06/2012
1
Arthritis (Polyarthritis)
06/2012
1
Infections
06/2012
Drug/Important Bio-Agent (IBA)
1
pembrolizumab
IBA
03/2024
1
Immune Checkpoint Inhibitors
IBA
03/2024
1
Atorvastatin (Lipitor)
FDA Link
03/2024
1
alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamide
IBA
01/2021
1
Wortmannin
IBA
01/2021
1
Antioxidants
IBA
01/2021
1
oleuropein
IBA
01/2021
1
NG-Nitroarginine Methyl Ester (L-NAME)
IBA
01/2021
1
A-factor (Streptomyces)
IBA
04/2020
1
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
09/2017
1
Integrin alphaVbeta3
IBA
12/2012
1
Ligands
IBA
12/2012
1
Peptides (Polypeptides)
IBA
12/2012
1
glycyl- arginyl- glycyl- aspartyl- seryl- proline
IBA
12/2012
1
arginyl-glycyl-aspartic acid
IBA
12/2012
1
Actins (F Actin)
IBA
12/2012
1
Gelatinases
IBA
06/2012
1
Gelatin
IBA
06/2012
1
Tissue Inhibitor of Metalloproteinase-1
IBA
06/2012
1
Matrix Metalloproteinases (MMPs)
IBA
06/2012
1
Metalloproteases (Metalloproteinases)
IBA
06/2012
Therapy/Procedure
1
Therapeutics
03/2024